INTRODUCTION

Traumatic brain injury (TBI) affects approximately 1.4 million individuals per year in the United
States and is a major cause of disability, death, and economic cost to patients, their families, and society as a whole. [19] Current treatment options for the prevention of secondary brain injury center on management of elevated intracranial pressure (ICP) and optimization of cerebral perfusion pressure. e most widely used methods for measuring ICP involve placement of a ventriculostomy or an intraparenchymal monitor. In addition to the risk of procedural complications such as bleeding and infection, these monitors also require specialized training for both physicians and nurses. e BEST-TRIP trial recently called into question the necessity of placing ICP monitors as they found no difference in outcome with the use of ICP monitoring. [6] In light of this study, the most recent Brain Trauma Foundation guidelines for TBI changed the recommendation for ICP monitoring from a specific set of criteria (Glasgow Coma Scale [GCS] 3-8+ abnormal computed tomography [CT] head, age >40 + posturing, or SBP <90 + normal CT head) to a more general recommendation that "ICP monitoring is recommended to reduce in-hospital and 2-week post injury mortality. " [5] is change is indicative of the fact that more objective parameters are needed to reliably predict which patients benefit from invasive ICP monitoring. A reliable, noninvasive predictor of increased ICPs would aid in effective triaging of patients to a neurosurgical center. It would also allow health-care providers at non neurosurgical centers to effectively employ therapeutic strategies to reduce suspected increased ICPs and determine who may need early intervention.
Recent studies have examined the efficacy of various noninvasive methods to predict increased ICPs and measurement of the optic nerve sheath diameter (ONSD) using ultrasound or CT has accurately predicted increased ICP or intracranial pathology. [1, 2, 4, 8, 10, 11, [16] [17] [18] 20, [23] [24] [25] [26] 28, [32] [33] [34] e optic nerve sheath is anatomically continuous with the dura mater and has a trabeculated subarachnoid space through which cerebrospinal fluid flows. Previous studies have shown that the fibrillary arrangement and density of the arachnoid trabeculations are responsible for the distensibility of the nerve sheath -allowing it to expand should ICP increase. ONSD has been validated in several studies as an independent predictor of morbidity and mortality in TBI. [14, 21] A limitation to this method is that it is dependent on operator technique, equipment availability, and variable anatomy. [3, 8, 9, 12, 23, 29, 31, 36, 37] CT measurement of ONSD has been studied and correlated with ICP; however, no studies have demonstrated an ability to predict developing elevated ICP. Marshall grading score is a CT score validated in the literature that classifies TBI according to the radiographic severity of injury. is has shown good prognostic value in predicting increased ICP in severe TBI patients. However, no studies in the literature that establish a quantitative relationship between Marshall grading system and other noninvasive methods to predict elevated ICPs. e purpose of our study is to establish a method for measuring ONSD by utilizing the initial CT head and demonstrate that such a technique, in correlation with Marshall grading, will help predict patients requiring an invasive ICP monitor on admission.
METHODS
is is a retrospective review of a prospectively collected database from two level II trauma centers. Study subjects included patients aged 18-90 years old who sustained a severe TBI (GCS ≤8) that had an ICP monitor placed on admission. All patients had a noncontrast CT head before placement of an ICP monitor. Patients receiving a craniotomy or craniectomy for decreasing suspected elevated ICPs before ICP monitor placement were excluded. Furthermore, patients with any documented orbitofacial trauma or concerns for cerebrospinal fluid leak were excluded from the study. e opening pressure after placement of the ICP monitor and peak ICP during hospitalization was recorded (mmHg). e same CT head was used to determine the Marshall score. We established a control group that consisted of 100 patients with negative CT head. McKesson Radiology PACS and Sectra PACS were used as the software for measuring ONSDs. e ONSD was measured by a team comprising of senior neurosurgery residents, staff neurosurgeon, and neuroradiologist at our respective institutions. e thickness of the CT slices was 5 mm in all subjects.
ONSD measurement protocol
Measurements of ONSD were obtained by adhering to a strict protocol established by our team to minimize interobserver variability. e mediastinum window was used to obtain all measurements. e ONSD was measured 3 mm behind the posterior aspect of the globe on axial sequences [ Figure 1 ]. Bilateral ONSD was measured in all patients. e average of ONSD was also used in our statistical analysis to help minimize the effects of the laterality of any lesions.
Data analysis
All data points were entered into our study database. e average ONSD of the left, right, and both eyes was calculated, and a linear regression analysis was conducted to determine the relationship between ONSD and ICP. Sensitivity, specificity, and positive predictive value calculations were also conducted. Fisher's exact test was used to determine significance, which was defined as P < 0.05. 
RESULTS
A total of 242 patients from 2012 to 2018 were identified from our database, and 204 patients (104 intervention, 100 control) met the inclusion criteria for this study. e average age in the intervention group was 37.1 years old and median initial GCS was 6.6. All ICP monitoring was in the form of external ventricular drain (EVD) placement. e total number of males overall (58 control and 83 intervention) was statistically significant (P = 0.0008).
Control group
Our control group consisted of 100 patients (58 males and 42 females) with no evidence any intracranial abnormality or severe head injury. Mean ONSD in the control group was 5.73 ± 0.58 mm. Mean ONSD in the male population was 5.82 ± 0.53 mm and 5.60 ± 0.63 mm in the female population. e ONSD range was 4.25-7.15 mm [ Table 1 ]. e average age of the control group was 49.1 ± 22.9 years old, and all patients were GCS 15 with no evidence of any pathology.
Intervention group
e average ONSD of both the eyes was 6.72 ± 0.79 mm. e average ONSD of the left eye was 6.76 ± 0.83 mm and the right eye was 6.63 ± 0.79 mm. e average age in the intervention group was 36.9 ± 15.1 years [ Table 2 ]. e difference in average ONSD from the control group was statistically significant (P < 0.0001). e average opening pressure at the time of ICP monitor placement was 16.6 ± 10 mmHg. Correlation analysis showed a trend in increasing opening ICP with increasing ONSD, particularly when ONSD was >6.0 mm (P < 0.0001, r = 0.40) [ Figure 2 ].
Further analysis revealed differences in the sensitivity and specificity between the laterality and mean ONSD measurements [ Figure 3 ]. e left ONSD in our population had a sensitivity of 92.2% and a specificity of 33.3% with a positive predictive value of 79.7% (P = 0.0002). e right ONSD had a sensitivity of 81.8% and a specificity of 25.9% with a positive predictive value of 75.9% (P = 0.41). e mean ONSD value in our population had a sensitivity of 87.2% and specificity of 33.3% with a positive predictive value of 78.8% (P = 0.04). A Marshall score ≥3 had a sensitivity of 66.2%, specificity of 81.4%, and positive predictive value of 91% (P = 0.0001). When the ONSD cutoff of 6.0 mm was combined with an admission of Marshall score ≥3, it yielded a sensitivity of 92.5%, specificity of 92.6%, and positive predictive value of 96.1% that a patient would have peak ICP ≥20 mmHg during the hospital course (P = 0.001).
DISCUSSION
Measurement of ONSD on CT is an alternative method of measuring ONSD that has been previously validated and was used in this study. [35] Its clinical application is similar; however, CT measurement has a tendency to overestimate ONSD by 10% in comparison to ultrasonography. [7] Different techniques have been employed in CT measurement of ONSD with authors measuring 3 mm behind the globe and others measuring up to 10 mm behind the globe. [3] is accounts for the great heterogeneity in normal cutoff values. e trabeculations in the anterior segment of the optic nerve sheath are sparse compared to the posterior segment, making it more distensible than the posterior segment. [12, 13] Prolonged distension of the optic nerve sheath results in papilledema. While a reliable indicator of elevated ICP, it can take hours, even days to develop, and is challenging to detect without a dilated funduscopic examination. [22] In a review by Bekerman et al., papilledema was detected in only 52% of patients with documented intracranial hypertension. [3] In contrast, evaluation of the optic nerve sheath utilizing ultrasonography detects increased ICP within seconds, making it more useful in an acute setting. [13, 30] Changes in ONSD can be observed instantaneously with any change in ICP. is phenomenon was described by Maissan et al. in a study of 18 TBI patients with ICP monitors that demonstrated simultaneous changes between ICP and ONSD. [23] We were able to show that an ONSD of 6.0 mm and Marshall score ≥3 were both highly sensitive markers of elevated ICP and, when combined, are reliable indicators of whether an ICP monitor should be placed. e ONSD of the left eye had a higher sensitivity for detecting elevated ICP. is was initially attributed to the effects of midline shift and laterality of lesions; however, we did not observe a pattern to support this. Our specificity of 92.5% and positive predictive value of 96.1% are among the highest in the literature utilizing CT-measured ONSD in TBI. Luyt et al. demonstrated 100% specificity with a cutoff of 5.0mm; however, their study was performed in non-traumatic patients. [22] Das et al. demonstrated a correlation between ONSD and Rotterdam scoring to indicate elevated ICP; however, their study did not include any invasive ICP monitoring to better quantify this correlation. [7] Our data demonstrate a statistically significant correlation between opening pressure on ICP monitor placement, peak ICP during hospitalization, and ONSD.
Literature review
Several studies have found a correlation between ONSD on ultrasound and ICP measured through traditional monitoring. Robba et al. showed that ONSD measured on ultrasound had the strongest correlation in predicting increased ICPs in patients with invasive ICP monitoring. [31] In another prospective observational study, Kimberly et al. showed that an ONSD >5.0 mm had a sensitivity and specificity of 88% and 93% in detecting ICP > 20 cm H 2 O in patients with an ICP monitor. [18] Raffiz et al. showed that the ONSD cutoff of 5.2 mm had a 95% sensitivity and 80% specificity in predicting increased ICPs. [29] ey also saw that these values were higher in patients who had acute increases in ICPs due to trauma compared to non-traumatic reasons. A study by Irazuzta et al. found that an ONSD >4.5 mm had 100% sensitivity in predicting increased ICPs. [15] In a 2011 meta-analysis, six studies looking at the results of 231 patients were reviewed. It showed a pooled sensitivity of 90% when using ONSD to detect increased ICP. However, this analysis is underpowered now that several more studies have been published as shown in Table 3 . [8] Another method of estimating ICP uses the ratio of the ONSD to the transverse diameter of the eyeball (eyeball transverse diameter), as described by Vaiman and Bekerman, who have conducted the largest studies to date analyzing ONSD on CT. e advantage of this technique is that it reduces variation that occurs from involuntary eye movements during CT scan. [3, 36, 37] In their review of 1766 adult patients, they assessed ONSD in patients with a variety of pathologies with intracranial hypo-or hyper-tension. ey found that, at ICPs below 13 mmHg and above 30 mmHg, there is no longer a linear correlation between ONSD and ICP. is was attributed to the already minimal CSF content within the optic nerve under normal conditions, and in low-pressure states, there can be no discernible changes due to the lack of CSF within the sheath. At ICPs >30 mmHg, it is likely that the sheath has reached maximum distensibility and there is no ability for the diameter of the optic nerve sheath to increase. [3] While these studies prove that this is a reliable noninvasive technique, generalizing such a method for measuring ONSD is difficult due to differences in operator experience, technique, and the modality used. is is evidenced by the great heterogeneity in the cutoff values as shown in Table 4 . Finding a normative value of ONSD in patients with negative CT head is important in establishing a quantitative relationship between increase ICP and its effect on optic nerve sheath distention. Ozgen and Ariyurek evaluated the orbital structures of 100 healthy subjects and found that the mean optic nerve sheath complex was 4.4 mm with an estimated normal range of 3.2-5.6 mm. [27] While this provides useful information, their standard measurements do not necessarily provide a clinical application because their point of measurement was more posterior than the commonly used Table 3 : Sensitivity and specificity analysis of optic nerve sheath diameter and Marshall score demonstrating the increasing sensitivity, specificity, and positive predictive value when combining Marshall score and optic nerve sheath diameter (P=0.001). measurements in the literature. Using our control group of 100 patients, which is among the largest control groups analyzing ONSD on CT, we were able to demonstrate that the normal ONSD range varies from 4.25 to 7.15 mm with a mean of 5.73 ± 0.58 mm that is consistent across both male and female subjects. In our intervention group, there were 4 times as many males in our intervention group (P < 0.0001), which is not unexpected given that males are twice as likely to suffer a TBI. [19] e age difference between the control (49.1 ± 22.9) and intervention (36.9 ± 15.1) groups was also statistically significant (P < 0.0001). We attribute this to the fact that ages 0-19 years old are more likely to suffer a TBI than any other age group. [19] Limitations e retrospective nature of our study is an inherent limitation due to selection bias. Another limitation of our study and utilizing CT head for ONSD measurement is the heterogeneity in the measurements of the ONSD due to the gantry differences between each scan. Patients' head positioning within the scanner, time from injury to CT scan, and presenting GCS also skew these measurements. Future studies utilizing this method should include appropriate cuts through the optic nerves so that the most accurate measurements of the ONSD can be obtained. An additional limitation is the variation in EVD placement as well as differences in measurement of the opening pressure as some measured opening pressure based on centimeters of water (cmH 2 O) above the external auditory canal while others utilized millimeters of mercury (mmHg) as measured by an electronic transducer. In addition, distention of the optic nerve sheath in response to changing ICP is dependent on the sheath's elasticity. Individual variability in the sheath's elastic properties makes establishing a quantitative relationship between ONSD and ICP difficult. e ICP values used in our study were the first recorded ICP numbers. Even though institutional protocol for placing ICP monitors warrants measurement of ICPs before any CSF drainage, it would be hard to reliably guarantee such practice in a retrospective study.
Measurement
CONCLUSION
Our study's main objective was to use ONSD on initial CT head to predict who would benefit from invasive ICP monitoring. We found that an ONSD >6.0 mm on CT in the setting of trauma strongly correlated with increased ICP and, when combined with Marshall scoring on admission, is a very sensitive and specific predictor for developing critical ICP (≥20 mmHg). is is the only large retrospective study to establish a large control group using CT measurement of ONSD. is cohort of individuals can be used as a control group in future studies. Although ONSD measured [20] 64 CT 5.3 88/79 Robba et al. [31] 64 US 5.0 N/A (AUC 0.91) Das et al. [7] 150 CT 6.0 97/42 Jeon et al. [16] 62 US 5.6 93.75/86.67 Raffiz et al. [29] 41 US 5.2 95.8/80.4 Bekerman et al. [3] 1766 CT 5.5* 90/86; 98/77 (intracranial hypotension) Vaiman et al. [37] 78 CT 5.5 91/83 Irazuzta et al. [15] 16 US 4.5 100/100 Luyt et al. [22] 67 CT 4.8; 5.0 92.9/97.6; 85.7/100 Mehrpour et al. [25] 32 US R-5.95 L-5.86 100/83 Sekhon et al. [33] 57 CT 6.0 97/42 Sahoo and Agrawal [32] 20 US 6.3 100/72.7 Amini et al. [1] 50 US 5.5 100/100 Qayyum and Ramlakhan [28] 24 US 5.0 100/75 Major et al. [24] 26 US 5.0 86/100 Moretti and Pizzi [26] 53 US 5.2 94/76 Goel et al. [11] 100 US 5.0 98.6/92.8 Geeraerts et al. [10] 38 MRI 5.82; 5.3 90/92; 100/100 Soldatos et al. [34] 50 US 5.7 65/74 Beare et al. [2] 14 US 4.2 100/86 Tayal et al. [35] 59 US 5.0 100/63 Geeraerts et al. [9] 31 US 5.7 100/68 Karakitsos et al. [17] 54 US 5.9 65/74 Blaivas et al. [4] 35 US 5.0 100/95 ONSD: Optic nerve sheath diameter on ultrasound has been validated as a reliable indicator of rising ICP, operator experience and variability of measurements limit its generalizability. Further studies are needed to better stratify ONSD values in combination with individual parameters, which may include the utilization of both dynamic ONSD monitoring (US) and precise ONSD measurements (CT). is combination of dynamic, objective, and validated criteria will be an effective tool that changes the way we determine which patients need invasive ICP monitoring.
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